BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 31285612)

  • 1. Genetic manipulation of autonomic nerve fiber innervation and activity and its effect on breast cancer progression.
    Kamiya A; Hayama Y; Kato S; Shimomura A; Shimomura T; Irie K; Kaneko R; Yanagawa Y; Kobayashi K; Ochiya T
    Nat Neurosci; 2019 Aug; 22(8):1289-1305. PubMed ID: 31285612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
    Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
    Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratification of ovarian tumor pathology by expression of programmed cell death-1 (PD-1) and PD-ligand- 1 (PD-L1) in ovarian cancer.
    Drakes ML; Mehrotra S; Aldulescu M; Potkul RK; Liu Y; Grisoli A; Joyce C; O'Brien TE; Stack MS; Stiff PJ
    J Ovarian Res; 2018 May; 11(1):43. PubMed ID: 29843813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reorganization of sympathetic preganglionic connections in cat bladder ganglia following parasympathetic denervation.
    de Groat WC; Kawatani M
    J Physiol; 1989 Feb; 409():431-49. PubMed ID: 2573724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic and parasympathetic innervation in cancer: therapeutic implications.
    Kamiya A; Hiyama T; Fujimura A; Yoshikawa S
    Clin Auton Res; 2021 Apr; 31(2):165-178. PubMed ID: 32926324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR3609 sensitizes breast cancer cells to adriamycin by blocking the programmed death-ligand 1 immune checkpoint.
    Li D; Wang X; Yang M; Kan Q; Duan Z
    Exp Cell Res; 2019 Jul; 380(1):20-28. PubMed ID: 30904483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer.
    Kawaguchi K; Suzuki E; Yamaguchi A; Yamamoto M; Morita S; Toi M
    Breast Cancer; 2017 Jan; 24(1):111-120. PubMed ID: 26942414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy.
    Machado CR; Camargos ER; Guerra LB; Moreira MC
    Hum Pathol; 2000 Jan; 31(1):3-10. PubMed ID: 10665906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic Cholangiocarcinoma.
    Guo XJ; Lu JC; Zeng HY; Zhou R; Sun QM; Yang GH; Pei YZ; Meng XL; Shen YH; Zhang PF; Cai JB; Huang PX; Ke AW; Shi YH; Zhou J; Fan J; Chen Y; Yang LX; Shi GM; Huang XY
    Front Immunol; 2021; 12():705378. PubMed ID: 34526987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary tumor resection for initially staged IV breast cancer: An emphasis on programmed death-ligand 1 expression, promoter methylation status, and survival.
    Erol T; İmamoğlu NE; Aydin B; Taşkiran ZE; Esendağli G; Kösemehmetoğlu K; Baykal A
    Medicine (Baltimore); 2019 Aug; 98(33):e16773. PubMed ID: 31415379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXP3+ Tregs and B7-H1+/PD-1+ T lymphocytes co-infiltrate the tumor tissues of high-risk breast cancer patients: Implication for immunotherapy.
    Ghebeh H; Barhoush E; Tulbah A; Elkum N; Al-Tweigeri T; Dermime S
    BMC Cancer; 2008 Feb; 8():57. PubMed ID: 18294387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adrenergic innervation and adrenergic receptor activity of the feline urinary bladder and urethra in the normal state and after hypogastric and/or parasympathetic denervation.
    Norlén L; Dahlström A; Sundin T; Svedmyr N
    Scand J Urol Nephrol; 1976; 10(3):177-84. PubMed ID: 1006178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1.
    Timaner M; Kotsofruk R; Raviv Z; Magidey K; Shechter D; Kan T; Nevelsky A; Daniel S; de Vries EGE; Zhang T; Kaidar-Person O; Kerbel RS; Shaked Y
    Oncogene; 2020 Jan; 39(1):187-203. PubMed ID: 31467431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA Class I Antigen Expression in Conjunctival Melanoma Is Not Associated With PD-L1/PD-1 Status.
    Cao J; Brouwer NJ; Jordanova ES; Marinkovic M; van Duinen SG; de Waard NE; Ksander BR; Mulder A; Claas FHJ; Heemskerk MHM; Jager MJ
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):1005-1015. PubMed ID: 29450544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Senescent cells re-engineered to express soluble programmed death receptor-1 for inhibiting programmed death receptor-1/programmed death ligand-1 as a vaccination approach against breast cancer.
    Chen Z; Hu K; Feng L; Su R; Lai N; Yang Z; Kang S
    Cancer Sci; 2018 Jun; 109(6):1753-1763. PubMed ID: 29675979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of cardiac innervation and function via the p75 neurotrophin receptor.
    Habecker BA; Bilimoria P; Linick C; Gritman K; Lorentz CU; Woodward W; Birren SJ
    Auton Neurosci; 2008 Jun; 140(1-2):40-8. PubMed ID: 18430612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Checkpoint Blockade Mediated by a Small-Molecule Nanoinhibitor Targeting the PD-1/PD-L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer.
    Zhang R; Zhu Z; Lv H; Li F; Sun S; Li J; Lee CS
    Small; 2019 Dec; 15(49):e1903881. PubMed ID: 31702880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin resistance in breast cancer xenografts and cell lines can be counterweighted by microRNA-140-3p, through PD-L1 suppression.
    Zhang X; Wang C; Huang C; Yang J; Wang J
    Histol Histopathol; 2023 Oct; 38(10):1193-1204. PubMed ID: 36621840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significance of evaluating tumor-infiltrating lymphocytes (TILs) and programmed cell death-ligand 1 (PD-L1) expression in breast cancer.
    Kurozumi S; Fujii T; Matsumoto H; Inoue K; Kurosumi M; Horiguchi J; Kuwano H
    Med Mol Morphol; 2017 Dec; 50(4):185-194. PubMed ID: 28936553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of programmed death-1, programmed death-ligand 1, programmed death-ligand 2 expression, and CD8(+) T cell density in primary tumors and metastatic lymph nodes from patients with stage T1-4N+M0 gastric adenocarcinoma.
    Gao Y; Li S; Xu D; Chen S; Cai Y; Jiang W; Zhang X; Sun J; Wang K; Chang B; Wang F; Hong M
    Chin J Cancer; 2017 Jul; 36(1):61. PubMed ID: 28754154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.